These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35723613)

  • 1. Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort.
    Pires da Rosa G; Ferreira E; Sousa-Pinto B; Bettencourt P; Espinosa G; Cervera R
    Scand J Rheumatol; 2023 Mar; 52(2):190-195. PubMed ID: 35723613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature.
    Franco AMM; Medina FMC; Balbi GGM; Levy RA; Signorelli F
    Lupus; 2020 Oct; 29(12):1528-1543. PubMed ID: 32814509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
    Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
    Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
    Riancho-Zarrabeitia L; Martínez-Taboada VM; Rúa-Figueroa I; Alonso F; Galindo-Izquierdo M; Ovalles J; Olivé-Marqués A; Mena Vázquez N; Calvo-Alén J; Menor Almagro R; Tomero Muriel E; Uriarte Isacelaya E; Boteanu A; Andres M; Freire González M; Santos Soler G; Ruiz-Lucea ME; Ibáñez-Barceló M; Castellví I; Galisteo C; Quevedo Vila V; Raya E; Narváez J; Expósito L; Hernández Beriaín JA; Horcada L; Aurrecoechea E; Pego Reigosa JM
    Clin Exp Rheumatol; 2021; 39(3):555-563. PubMed ID: 32828148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical characteristics of 37 antiphospholipid syndrome patients complicated by autoimmune hemolytic anemia].
    Zhang JT; Qi WT; Zhou YZ; Huang C; Zhao JL; Li MT; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2023 Feb; 62(2):147-155. PubMed ID: 36740405
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus?
    Gómez-Puerta JA; Martín H; Amigo MC; Aguirre MA; Camps MT; Cuadrado MJ; Hughes GRV; Khamashta MA
    Medicine (Baltimore); 2005 Jul; 84(4):225-230. PubMed ID: 16010207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing antiphospholipid syndrome: 'extra-criteria' manifestations and technical advances.
    Sciascia S; Amigo MC; Roccatello D; Khamashta M
    Nat Rev Rheumatol; 2017 Sep; 13(9):548-560. PubMed ID: 28769114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study.
    da Rosa GP; Sousa-Pinto B; Ferreira E; Araújo O; Barilaro G; Bettencourt P; Cervera R; Espinosa G
    Arthritis Res Ther; 2022 Jan; 24(1):9. PubMed ID: 34980238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retinal vascular lesions in systemic lupus erythematosus and secondary antiphospholipid syndrome].
    Ermakova NA; Alekberova ZS; Reshetniak TM; Kalashnikova LA; Kosheleva NM
    Vestn Oftalmol; 2005; 121(5):31-6. PubMed ID: 16274063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies and clinical features of the antiphospholipid syndrome as criteria for systemic lupus erythematosus.
    Merrill JT
    Lupus; 2004; 13(11):869-76. PubMed ID: 15580985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
    Campos LM; Kiss MH; D'Amico EA; Silva CA
    Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
    Erton ZB; K Leaf R; de Andrade D; Clarke AE; Tektonidou MG; Pengo V; Sciascia S; Ugarte A; Belmont HM; Gerosa M; Fortin PR; Lopez-Pedrera C; Atsumi T; Zhang Z; Cohen H; Ramires de Jesús G; Branch DW; Wahl D; Andreoli L; Rodriguez-Almaraz E; Petri M; Barilaro G; Zuo Y; Artim-Esen B; Willis R; Quintana R; Vendramini MB; Barber MW; Bertolaccini ML; Roubey R; Erkan D
    Lupus; 2022 Dec; 31(14):1770-1776. PubMed ID: 36206383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J; Cabral AR; Alarcón-Segovia D
    J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.
    Abreu MM; Danowski A; Wahl DG; Amigo MC; Tektonidou M; Pacheco MS; Fleming N; Domingues V; Sciascia S; Lyra JO; Petri M; Khamashta M; Levy RA
    Autoimmun Rev; 2015 May; 14(5):401-14. PubMed ID: 25641203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Criteria Manifestations of Juvenile Antiphospholipid Syndrome.
    Miyamae T; Kawabe T
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33802787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies?
    Noureldine MH; Harifi G; Berjawi A; Haydar AA; Nader M; Elnawar R; Sweid A; Al Saleh J; Khamashta MA; Uthman I
    Lupus; 2016 Nov; 25(13):1397-1411. PubMed ID: 27225212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.
    Ma J; Song H; Wei M; He Y
    Clin Rheumatol; 2018 May; 37(5):1295-1303. PubMed ID: 28748509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lupus erythematosus and antiphospholipid syndrome - diagnostic and therapeutic problems].
    Zdrojewski Z
    Wiad Lek; 2018; 71(1 pt 1):40-46. PubMed ID: 29558350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.